If you have questions about GLP-1 medications, changes in your metabolism, or how to manage your energy levels while on these treatments, dont hesitate to reach out
In contrast to these results, a study using nationwide registry data from Sweden, Denmark, and Norwayinvolving 121,254 new GLP-1 RA users and 185,027 new SGLT-2 inhibitor users documented 557 intestinal obstruction events, with no significant correlation between GLP-1 RA use and increased intestinal obstruction risk, thereby refuting earlier safety concerns [12]
In a 2021 clinical trial, some participants lost more than 2% of their body weight within 4 weeks
Its also suitable for those who wish to maintain high energy levels and manage occasional digestive discomforts such as bloating
Injection site infections are rare but entirely preventable
Central nervous system regulation of eating: insights from human brain imaging